New Key Statistics Module, Z-Score and F-Score
NAS:NRIX Key Ratios
| Market Cap $ M | 970.97 |
| Enterprise Value $ M | 698.12 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.35 |
| Price/Sales | 10.07 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 80.00 |
| EPS (TTM) $ | -2.66 |
| Beneish M-Score | -3.14 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -43.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.44 |
| EV-to-EBITDA | -4.88 |
| PEG | -- |
| Shares Outstanding M | 61.07 |
| Net Margin (%) | -178.93 |
| Operating Margin % | -194.51 |
| Pre-tax Margin (%) | -178.82 |
| Quick Ratio | 2.86 |
| Current Ratio | 2.86 |
| ROA % (ttm) | -42.64 |
| ROE % (ttm) | -63.65 |
| ROIC % (ttm) | -129.39 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.54 |
NRIX Number of Guru Trades
NRIX Volume of Guru Trades
Gurus Latest Trades with NAS:NRIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NRIX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nurix Therapeutics Inc Insider Transactions
No Available Data
News about NAS:NRIX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers